← All injections

Ultrasound · Elbow

Common Extensor Tendon Origin Injection (Lateral Epicondyle)

elbowtennis elbowcet

Treats

  • Lateral epicondylitis with tendon surface pain or degeneration

Contraindications

  • Active local skin infection at entry site (absolute)
  • Known allergy to local anesthetic, steroid, or antiseptic prep
  • Therapeutic anticoagulation — review case-by-case
  • Uncontrolled diabetes (relative)
  • High-grade tendon tear (relative — favor regenerative injectate over steroid)

Pre-procedure checklist

  • Confirm patient identity (two identifiers)
  • Confirm procedure, side, and site — mark with patient awake
  • Review allergies and anticoagulation
  • Confirm informed consent
  • Pre-scan to map radial nerve and radial recurrent artery
  • Time-out immediately before needle entry

Positioning

  • Supine; elbow 20-40° flexed; hand on abdomen
Positioning

Probe

  • High-frequency linear probe (6-13 MHz)
Probe

Landmarking — find the view

  • Visual Cue: The “Fibrillar Footprint” — Identify the bright, organized fibers of the CET attaching to the lateral epicondyle.
  • Slide the probe slightly anteriorly to identify the landmark bony contour of the radial head.
  • Check for any hypoechoic “tears” or calcifications within the footprint.
  • Map the radial nerve and the radial recurrent artery before choosing your needle path.

The correct ultrasound view

  • Crisp fibrillar tendon superficial to thin bright ligament band
The correct ultrasound view

Needle corridor

  • Distal → proximal path between skin/fat (above) and tendon surface (below) for peritendinous steroid
Needle corridor

Avoid

  • Radial nerve (superficial branch runs anterior to the radial head at this level — identify before entry)
  • Radial recurrent artery
  • Lateral ulnar collateral ligament (LUCL) — originates at the lateral epicondyle; deep injection into or through the LUCL risks posterolateral rotatory instability (PLRI). Keep needle superficial to the tendon surface.
  • Intratendinous steroid

Steps

  1. 1Peritendinous steroid: deposit aliquots in the plane BETWEEN the fascial/fat layer and the tendon surface — NOT within the fibrillar tendon itself.
  2. 2For regenerative injectates (PRP, percutaneous tenotomy), target intratendinous diseased zones — this is a different technique and not for steroid.
  3. 3STOP IMMEDIATELY if the patient reports electric, shooting, or paresthetic sensations.

Tips

  • Limit corticosteroid here to 1-2 injections lifetime — and consider non-steroid alternatives first (see pearls).
  • If color Doppler shows the radial recurrent artery in the planned path, abandon and re-plan.

Resident pearls

  • Corticosteroid for tendinopathy provides short-term relief but is associated with WORSE long-term outcomes in published RCTs (Coombes BK et al. JAMA 2013;309:461). Consider PRP, percutaneous tenotomy, or peritendinous saline as alternatives. If steroid is used, single low-dose injection only.
  • The radial collateral ligament is deep — forming the deep 30-50% of the common-origin footprint.
  • Avoid placing corticosteroid directly into the tendon fibers to prevent future rupture.

Supplies

  • 3 mL Syringe
  • 25G or 27G 1" Needle
  • 18G Drawing Needle
  • 1% Lidocaine (1-2 mL)
  • Triamcinolone 20 mg OR Dexamethasone 4 mg (single low-dose, peritendinous only)
  • Alcohol Swabs (vial tops)
  • Betadine/Chloraprep
  • Sterile Gloves
  • Sterile 4x4 Gauze Pads
  • Sterile Towels & Drapes
  • Adhesive Bandage (Band-Aid)
  • Washcloth/Towel (gel cleanup)
  • Needle Disposal Safety Cap
  • Sterile probe cover & gel

Post-procedure

  • Apply a clean dressing; remove after 24 hours.
  • Local anesthetic relief for 1-4 hours; steroid begins 24-72 hours.
  • Steroid 'flare' in 2–10% — manage with ice and acetaminophen.
  • Rest the forearm 24-48 hours; avoid heavy gripping for 1 week.
  • Return immediately for: spreading redness, swelling, fever, or disproportionate pain.
  • Diabetics: expect 50-100 mg/dL glucose rise for 3-5 days.
  • Maximum 1-2 steroid injections at this site lifetime — recurrent dosing worsens outcomes.